Nutraceuticals and Pharmaceuticals from Marine Fish and Invertebrates
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 43114
Special Issue Editor
Interests: food quality and safety; food technology; seafood; fatty acids; seaweed antioxidans; marine bioactives
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the continuous search for sustainable natural sources of bioactive compounds for the food and pharmaceutical industries, marine organisms, comprising approximately one-half of the global biodiversity, are one of the most important and recently investigated bio-resources. Bioactive compounds isolated from marine micro and macroalgae, animals, and microorganisms are considered a safe and environmentally friendly alternative to existing synthetic nutraceuticals and pharmaceuticals. In this Special Issue of Marine Drugs, you are invited to submit recent advances in research of the bioactive compounds from marine fish and Invertebrates (both wild-caught and cultured) and their by-products, including enzymes, pigments, peptides, proteins, essential fatty acids (particularly eicosapentaenoic and docosahexaenoic acid), vitamins, and minerals, their chemistry and biological activity, as well as innovations in their production/extraction and application as nutraceuticals, therapeutic agents and pharmaceuticals. We also welcome research on the role of these components in protecting human health, standardization of these compounds through studies and trials, research on safety, purity, and dosage of the ingredients in commercial products and development of new nutraceuticals, therapeutic agents, and pharmaceuticals.
Prof. Dr. Vida Šimat
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Extraction method
- Bioactive peptides
- Biological activity
- Food application
- Therapeutic effect
- Enzyme inhibitors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.